..., instructions or products referred to in the content or advertisements. 2023 Focal therapy Renal cell carcinoma Population-based study Trends Ablation techniques Kidney Renal cell carcinoma (RCC) represents around 3% of all cancers and remains one of the most lethal urological malignancies...

...; Marc-Oliver Grimm; Oliver W. Hakenberg; Martin Schostak Background: Focal therapy (FT) is an option to treat localized prostate cancer (PCa) and preserve healthy prostate tissue in order to reduce known side effects from primary whole-gland treatment. The available FT modalities are manifold. Until now...

..., quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Quality of life Prostate cancer Decisional regret Focal therapy Vascular...

... to in the content or advertisements. Antibiotics Focal therapy High-intensity focused ultrasound HIFU Prostatic neoplasms Urinary tract infection Organ-sparing focal therapies of localized prostate cancer aim to efficiently treat intraprostatic cancer lesions and to avoid side effects of whole...

...Bernd Rosenhammer; Christoph Niessen; Laura Rotzinger; Julian Reiss; Marco J. Schnabel; Maximilian Burger; Johannes Bründl Introduction: Focal therapy (FT) by high-intensity focused ultrasound (HIFU) is an emerging option for localized prostate cancer (PC). Due to the lack of long-term data...

..., compared with men with >pT2a diseases (p = 0.012). Conclusions: Biopsy tumor unilaterality, diagnostic PSA ≤4 ng/ml and race are independent predictors of pT2a in low-risk prostate cancer. These three preclinical variables may be a useful reference to begin the selection process for focal therapy in men...